Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (271-280 of 675) with videos related to

Pageof 68
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Homocysteine activates platelets in vitroIrwin V Mohan, I Anita Jagroop, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|April 22, 2014
Psoriasis and Vascular Risk : An UpdateNiki Katsiki, Panagiotis Anagnostis, Vasilios G Athyros, et al.
Angiology|January 2, 2016
Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery StenosisKosmas I Paraskevas, Dimitri P Mikhailidis, Frank J Veith, et al.
Archives of Medical Science : AMS|January 21, 2016
Ear lobe crease: a marker of coronary artery disease?Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
Journal of Diabetes and Its Complications|February 4, 2018
Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistanceMohsen Mazidi, Andre-Pascal Kengne, Niki Katsiki, et al.
Lipids in Health and Disease|September 19, 2018
Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANESMohsen Mazidi, Niki Katsiki, Andre Pascal Kengne, et al.
Angiology|April 9, 2011
Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?Georgios N Daskalopoulos, Artemis Karkanaki, Asterios Karagiannis, et al.
Expert Opinion on Therapeutic Targets|January 26, 2011
Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitusNiki Katsiki, Dimitri P Mikhailidis, Anna Gotzamani-Psarrakou, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 20, 2002
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymesEvangelos Rizos, Eleni Bairaktari, Emmanouel Ganotakis, et al.
Expert Opinion on Pharmacotherapy|June 4, 2008
Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?Anna I Kakafika, Vasilios G Athyros, Konstantinos Tziomalos, et al.
Pageof 68

Showing results (271-280 of 675) with videos related to

Sort By:
Pageof 68
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Homocysteine activates platelets in vitroIrwin V Mohan, I Anita Jagroop, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|April 22, 2014
Psoriasis and Vascular Risk : An UpdateNiki Katsiki, Panagiotis Anagnostis, Vasilios G Athyros, et al.
Angiology|January 2, 2016
Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery StenosisKosmas I Paraskevas, Dimitri P Mikhailidis, Frank J Veith, et al.
Archives of Medical Science : AMS|January 21, 2016
Ear lobe crease: a marker of coronary artery disease?Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
Journal of Diabetes and Its Complications|February 4, 2018
Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistanceMohsen Mazidi, Andre-Pascal Kengne, Niki Katsiki, et al.
Lipids in Health and Disease|September 19, 2018
Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANESMohsen Mazidi, Niki Katsiki, Andre Pascal Kengne, et al.
Angiology|April 9, 2011
Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?Georgios N Daskalopoulos, Artemis Karkanaki, Asterios Karagiannis, et al.
Expert Opinion on Therapeutic Targets|January 26, 2011
Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitusNiki Katsiki, Dimitri P Mikhailidis, Anna Gotzamani-Psarrakou, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 20, 2002
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymesEvangelos Rizos, Eleni Bairaktari, Emmanouel Ganotakis, et al.
Expert Opinion on Pharmacotherapy|June 4, 2008
Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?Anna I Kakafika, Vasilios G Athyros, Konstantinos Tziomalos, et al.
Pageof 68